Skip to main content

Table 3 Major compounds in CKI identified by HPLC–MS

From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation

No.

Theoretical value

PPM

Time (min)

MS/MS ions

Structure

Rresumption

1

218.10577

− 4.06

6.007

152.01067, 123.00785, 108.02056, 85.02821, 151.03957

View full size image

N-methylcytisine

2

246.17360

2.94

2.135

163.07516, 134.09622, 59.04988

Sophocarpine

3

248.18896

− 3.67

2.351

179.05530,161.04527,89.02322

Sophoridine

4

248.18910

− 3.17

1.834

176.3145, 148.2457, 112.2569

Matrine

5

262.16841

− 3.65

2.592

181.05049,119.03400,89.02325

Oxysophocarpine

6

264.18394

− 0.52

24.975

247.2548, 205.7581, 148.2567

Oxymatrine

7

264.18395

− 3.19

50.755

211.06097, 167.07062, 149.05995, 123.04412, 71.01385

Sophoranol

8

384.22630

4.13

3.381

110.0603, 96.04457, 94.06555, 92.04989, 67.05498

Macrozamin

9

446.12215

− 2.50

2.976

263.07761,221.06653,179.05548,161.04482

View full size image

Trifolirhizin

10

764.25163

0.84

17.229

152.01073, 123.04407, 108.0206,

View full size image

Liriodendrin